Skip to main content
Glama

Guidetopharmacology

by io.github.pipeworx-io

Discover Tools

discover_tools
Read-onlyIdempotent

Find tools by describing the data or task. Use when you need to browse, search, look up, or discover what tools exist for: SEC filings, financials, revenue, profit, FDA drugs, adverse events, FRED economic data, Census demographics, BLS jobs/unemployment/inflation, ATTOM real estate, ClinicalTrials, USPTO patents, weather, news, crypto, stocks. Returns the top-N most relevant tools with names, descriptions, and full input schemas (with curated examples) — each result is ready to call directly, no second schema lookup needed. Call this FIRST when you have many tools available and want to see the option set (not just one answer).

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
qNoAlias for query.
taskNoAlias for query.
limitNoMaximum number of tools to return (default 20, max 50)
queryYesNatural language description of what you want to do (e.g., "analyze housing market trends", "look up FDA drug approvals", "find trade data between countries"). Accepts task, q, description, search as aliases.
searchNoAlias for query.
descriptionNoAlias for query.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.3/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool as readOnlyHint=true and idempotentHint=true, so safety is clear. The description adds value by explaining the output includes 'full input schemas (with curated examples)' and that results are 'ready to call directly', which goes beyond annotations. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is four sentences: purpose, usage examples, output details, and workflow guidance. It is front-loaded and informative without being verbose. Minor redundancy in listing aliases could be trimmed.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description explains what is returned (names, descriptions, schemas). It covers the main inputs and their purpose, and provides usage context. It is sufficiently complete for a discovery tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so parameters are already documented. The description provides example queries and notes that the tool accepts multiple aliases, but does not add deep semantics beyond the schema. It is adequate but not exceptional.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: 'Find tools by describing the data or task.' It lists specific domains (SEC filings, FDA drugs, etc.) and emphasizes that it returns tools ready to call, which distinguishes it from sibling tools that likely perform specific actions.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use when you need to browse, search, look up, or discover what tools exist' and 'Call this FIRST when you have many tools available and want to see the option set.' This provides clear guidance on when to use it and suggests a primary workflow.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Guidetopharmacology toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Many tools have overlapping purposes, such as multiple ask_pipeworx variants (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) that differ only subtly, and a large set of prediction market tools (bet_research, polymarket_arbitrage, polymarket_edges, etc.) that can be easily confused. Entity tools like entity_profile, recent_changes, and compare_entities also overlap significantly. An agent would struggle to pick the right tool without careful reading.

Naming Consistency2/5

Tool names mix snake_case (ask_pipeworx, deep_research, forget) and descriptive phrases without a consistent verb_noun pattern. Some start with verbs (compare, generate, scan) while others are nouns or compound phrases (pipeworx_trending, polymarket_fill_risk). This inconsistency makes it hard to predict tool names.

Tool Count2/5

With 35 tools, this MCP server is overly large and covers many diverse domains (data querying, prediction markets, pharmacology, npm scanning, brand visibility, etc.). Typically, a well-scoped server has 5-15 tools; 35 is excessive and suggests a lack of focus, making it unwieldy for an agent to manage.

Completeness2/5

Despite the large number of tools, the server has notable gaps. For example, the pharmacology section only offers search and interaction tools but no create/update/delete. The memory tools are limited to save/recall/forget. Many meta-tools (discover_tools, suggest_questions) exist but add little substance. The server covers many domains superficially rather than providing full lifecycle coverage for any one domain.

Resources